Top Markets
Coin of the day
GemVax&KAEL Co.,Ltd GemVax&KAEL Co.,Ltd

GemVax&KAEL Co.,Ltd

082270
Pozycja w akcjach #15775
GemVax & KAEL Co., Ltd. specializes in manufacturing chemical filtration... GemVax & KAEL Co., Ltd. specializes in manufacturing chemical filtration systems and gas purification units, primarily for the semiconductor industry. The company operates through two main segments: Environmental Pollution Control and Bio Business. Its Environmental Pollution Control division focuses on creating essential filters for semiconductor and display fabrication processes, in addition to developing equipment for air quality management and odor prevention. Concurrently, the Bio Business division is dedicated to advancing its innovative telomerase-derived peptide drug, GV1001, through preparations for domestic and international Phase 2 and 3 clinical trials. These trials are designed to address various conditions, including Alzheimer's disease, benign prostatic hyperplasia, and progressive supranuclear palsy. Founded on March 10, 1998, GemVax & KAEL Co., Ltd. is headquartered in Daejeon, South Korea.
Cena akcji
$7.54
Kapitalizacja rynkowa
$331.60M
Zmiana (1 dzień)
-3.79%
Zmiana (1 rok)
-75.66%
Kraj
KR
Handel GemVax&KAEL Co.,Ltd (082270)

Kategoria

Historia ceny akcji dla GemVax&KAEL Co.,Ltd (082270)
Najwyższa cena zamknięcia: $7.54 dnia 2026-09-01

Najniższa cena zamknięcia: $6.98 dnia 2005-06-01
Historia cen akcji firmy GemVax&KAEL Co.,Ltd od 2005 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) 3.21%
2025 88.44%
2024 8.58%
2023 1.92%
2022 -33.81%
2021 -30.60%
2020 -25.31%
2019 163.75%
2018 -18.47%
2017 20.91%
2016 -44.19%
2015 31.29%
2014 23.84%
2013 -61.74%
2012 -4.64%
2011 196.44%
2010 103.86%
2009 147.53%
2008 -42.84%
2007 -19.82%
2006 -33.32%
2005 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$297.13 -
US
$330.64 18.03%
DE
$341.49 38.69%
FR
$166.56 58.69%
DE
$955.68 25.85%
US